Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Spectacular new images from inside the body

19.11.2010
In a ceremony attended by Bavarian Minister President Horst Seehofer, Siemens presented the university hospital Klinikum rechts der Isar in Munich with the world’s first device that combines magnetic resonance imaging with positron emission tomography.

The department of nuclear medicine at the university hospital Klinikum rechts der Isar of the Munich Technical University today started clinical use testing with a world’s first in medical technology, thereby opening up new perspectives for the diagnosis of diseases such as cancer or dementia.


The combination of a magnetic resonance tomograph (MR) and a positron emission tomograph (PET) in one device allows doctors – for the first time – to simultaneously see the position of internal organs, how these are working, as well as their metabolism, all in a single image. This may help doctors to make a more accurate diagnoses by not only seeing where a tumor is in the body, but also its type and its activity. Moreover it may display how the body reacts to medication administered to the patient. The device, called the Biograph mMR*, has been developed by Siemens Healthcare and is a pioneering achievement in medical imaging.

The Biograph mMR combines two technologies that normally would not be able to work next to each other: Magnetic resonance imaging uses a strong magnetic field and electromagnetic waves, while positron emission tomography uses low-dose radioactively charged radiopharmaceuticals, with which the patient is injected before the examination. These radiopharmaceuticals react with the body tissue and the resulting radiation is measured and finally converted into an image. According to physics applied in these imaging techniques, those two technologies should conflict with each other and make simultaneous imaging impossible. But the Biograph mMR is designed to overcome this physical hurdle. Thanks to funding of the Deutsche Forschungsgemeinschaft (DFG) the first systems will be installed in Germany.

In his remarks at the celebratory commissioning of the device, Bavarian Minister President Horst Seehofer said, “Bavaria’s high-tech architects like Siemens, combined with the top-notch science that we have here in both university hospitals in Munich, result in the kind of strong partnership that contribute to Bavaria’s strength and prosperity and that is the envy of many around the world. Before the upcoming holiday season, Bavaria will enact a new future-focused program called “Bavaria on the Move.” Under this program, we will continue to make significant investments in research and technology throughout all parts of the Bavarian state. This is, and will remain, Bavaria’s sovereign path toward prosperity and employment.”

MRI and PET are already well-established imaging techniques in medicine, and have been used for a long time to answer important clinical questions. Now, the combination of both technologies in one system is expected to change the diagnosis of many diseases, including many types of cancer as well as dementia. ”Together with our partner Siemens we are entering a new dimension in diagnostic imaging today“, said Prof. Dr. Markus Schwaiger, Director of the department for nuclear medicine at the university hospital. „We’ve initiated clinical use testing of Biograph mMR in an effort to diagnose diseases at a very early stage; to see the progression of disease and to use that information to develop a therapy plan precisely focused on the respective patient. Furthermore, we plan to use the system for cancer follow-up in the long run, by reducing radiation exposure by the use of the system.“

In addition, the combination of the two systems will significantly cut the time needed for an examination compared to when two separate systems are used. The same works for the space – where room was needed for two large machines before, now only one combined machine is required. That gives hospitals more space for patients. “We can master the challenges of our healthcare systems only if we detect diseases as early as possible and treat them appropriately, while keeping an eye on costs,” explained Dr. Hermann Requardt, CEO of the Siemens Healthcare Sector. “Our Biograph mMR is a tool for doctors, enabling them to more quickly and accurately collect information on the type, stage, and progress of cancers, for example. The system may also be suitable for monitoring the progress and effectiveness of therapies. The Biograph mMR at the hospital Rechts der Isar clinic is a milestone in image-based diagnostics.”

Combining MRI and PET was a great technological feat, as the two processes using different physical effects could normally not work close to each other. The magnetic fields generated in MRI interfere with usual PET detectors, what until now prevented simultaneously taken high-resolution human images. Patients had to be scanned in two separate systems, with a certain time interval between the exams. With the Biograph mMR, Siemens has developed the first system that provide highly innovative PET detectors, which work very well inside an MR system.

Tanja Schmidhofer | Uni München
Further information:
http://www.siemens.com/press/healthcare/biograph-mmr

More articles from Medical Engineering:

nachricht Potentially life-saving health monitor technology designed by Sussex University physicists
10.01.2018 | University of Sussex

nachricht 2 million euros in funding for new MR-compatible electrophysiological brain implants
18.12.2017 | Max-Planck-Institut für biologische Kybernetik

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

Im Focus: Autoimmune Reaction Successfully Halted in Early Stage Islet Autoimmunity

Scientists at Helmholtz Zentrum München have discovered a mechanism that amplifies the autoimmune reaction in an early stage of pancreatic islet autoimmunity prior to the progression to clinical type 1 diabetes. If the researchers blocked the corresponding molecules, the immune system was significantly less active. The study was conducted under the auspices of the German Center for Diabetes Research (DZD) and was published in the journal ‘Science Translational Medicine’.

Type 1 diabetes is the most common metabolic disease in childhood and adolescence. In this disease, the body's own immune system attacks and destroys the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fachtagung analytica conference 2018

15.01.2018 | Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

 
Latest News

Black hole spin cranks-up radio volume

15.01.2018 | Physics and Astronomy

A matter of mobility: multidisciplinary paper suggests new strategy for drug discovery

15.01.2018 | Life Sciences

New method to map miniature brain circuits

15.01.2018 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>